Clinical trial
Effect of Active Hexose Correlated Compound to Clinical and Immunological Response in Tuberculosis-HIV (Human Immunodeficiency Virus) Infection
NCT05100758 is registered in ClinicalTrials.gov with Hasanuddin University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Active Hexose Correlated Compound to Clinical and Immunological Response in Tuberculosis-HIV (Human Immunodeficiency Virus) Infection
- Lead sponsor
- Hasanuddin University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- October 1, 2018
- Completion date
- December 1, 2020
- Enrollment
- 120 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
human immunodeficiency virus, tuberculosis